Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangxi Shengte Pharmaceutical is a Chinese pharmaceutical company based in Guilin, Guangxi, specializing in the research, development, and large-scale manufacturing of finished dosage forms. The company operates multiple GMP-certified production lines for tablets, capsules, and granules, focusing primarily on anti-infective and general medicine categories. Their product portfolio includes widely used antibiotics such as Roxithromycin and Norfloxacin, as well as treatments for common ailments like cough and fever. Guangxi Shengte serves the domestic Chinese market through a robust distribution network, positioning itself as a reliable provider of essential generic medicines. The company emphasizes quality control and adherence to national pharmaceutical standards to maintain its competitive edge in the regional healthcare sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangxi Shengte Pharmaceutical.